Efficacy of vagus nerve stimulation in the treatment of depression

Expert Review of Neurotherapeutics

Volumn 10, Issue 1, 2010, Pages 87-92

  Grimm, Simone ^a,b   Bajbouj, Malek ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Brain stimulation; Major depression; Therapy resistance; Vagus nerve; Vagus nerve stimulation

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROTRANSMITTER;

4 AMINOBUTYRIC ACID RELEASE; ANTICONVULSANT ACTIVITY; ASYSTOLE; BRADYCARDIA; BRAIN DEPTH STIMULATION; CLINICAL TRIAL; DYSPEPSIA; DYSPHAGIA; DYSPNEA; ELECTROCONVULSIVE THERAPY; ELECTROPHYSIOLOGY; GABAERGIC SYSTEM; HEART PALPITATION; HOARSENESS; HUMAN; KINDLING; LARYNX SPASM; MAJOR DEPRESSION; MONOAMINERGIC SYSTEM; NECK PAIN; NEUROBIOLOGY; NEUROIMAGING; NONHUMAN; PARESTHESIA; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; REVIEW; THERAPY RESISTANCE; THROAT IRRITATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; VAGUS NERVE STIMULATION; VOMITING; WOUND INFECTION;

DEPRESSION; HUMANS; VAGUS NERVE STIMULATION;

EID: 74949121508     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.09.138     Document Type: Review

References (55)

1. American Psychiatric Association, Task Force on DSM IV. Diagnostic and Statistical Manual of Mental Disorders - Text Revision (DSM IVTR) (4th Edition). American Psychiatric Association, Washington, DC, USA, 345-429 (2002).
2. Wells KB, Stewart A, Hays RD et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes study. JAMA 262, 914-919 (1989).
3. Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J. Clin. Psychiatry 60(Suppl. 2), 57-62 (1999).
4. Rich CL, Young D, Fowler RC. San Diego suicide study. I. Young vs old subjects. Arch. Gen. Psychiatry 43(6), 577-582 (1986).
5. Arató M, Demeter E, Rihmer Z, Somogyi E. Retrospective psychiatric assessment of 200 suicides in Budapest. Acta Psychiatr. Scand. 77(4), 454-456 (1988).
6. Dorpat TL, Ripley HS. A study of suicide in the Seattle area. Compr. Psychiatry 1, 349-359 (1960).
7. Foster T, Gillespie K, McClelland R, Patterson C. Risk factors for suicide independent of DSM-III-R Axis I disorder. Case - control psychological autopsy study in Northern Ireland. Br. J. Psychiatry 175, 175-179 (1999).
8. Henriksson MM, Aro HM, Marttunen MJ et al. Mental disorders and comorbidity in suicide. Am. J. Psychiatry 150(6), 935-934 (1993).
9. Ormel J, VonKorff M, Ustun TB, Pini S, Korten A, Oldehinkel T. Common mental disorders and disability across cultures. JAMA 272. 1741-1748 (1994).
10. Kessler R, Barber C, Birnbaum H et al. Depression in the workplace: Effects on short-term disability. Health Affairs 18, 163-171 (1999).
11. Fava M, Davidson K, Definition and epidemiology of treatment-resistant depression. Psychiatric Clin. N. Am. 19, 179-200 (1996).
12. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 34, 13-25 (2002).
13. Ben-Menachem E. Modern management of epilepsy: vagus nerve stimulation. Baillieres Clin. Neurol. 5, 841-848 (1996).
14. Landy HJ, Ramsay RE, Slater J, Casiano RR, Morgan R. Vagus nerve stimulation for complex partial seizures: surgical technique, safety, and efficacy. J. Neurosurg. 78, 26-31 (1993).
15. Rush AJ, Siefert SE. Clinical issues in considering vagus nerve stimulation for treatment-resistant depression. Exp. Neurol. 219(1), 36-43 (2009).
16. Vonck K, De Herdt V, Boon P. Vagal nerve stimulation - a 15-year survey of an established treatment modality in epilepsy surgery. Adv. Tech. Stand. Neurosurg. 34, 111-146 (2009).
17. George MS, Sackeim HA, Rush AJ et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol. Psychiatry 47, 287-295 (2000).
18. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res. 42, 203-210 (2000).
19. Sackeim HA, Rush AJ, George MS et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25, 713-728 (2001).
20. Rush AJ, Marangell LB, Sackeim HA et al. Vagus nerve stimulation for treatmentresistant depression: a randomised, controlled acute phase trial. Biol. Psychiatry 58, 347-354 (2005). The first paper in which short-term effects of vagus nerve stimulation (VNS) are described.
21. Rush AJ, Sackeim HA, Marangell LB et al. Effects of 12 month vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol. Psychiatry 58, 355-363 (2005). • The first paper in which the potential long-term effects of VNS are described.
22. George MS, Rush AJ, Marangell LB et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol. Psychiatry 58, 364-373 (2005).
23. Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol. Psychiatry 64(6), 455-460 (2008).
24. Zahas Z, Marangell LB, Husain MM et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J. Clin. Psychiatry 66, 1097-1104 (2005).
25. Carpenter LL, Moreno FA, Kling MA et al. Effects of vagus nerve stimulation on cerebrospinal fluid monoamine acid concentrations in depressed patients. Biol. Psychiatry 56, 418-426 (2004).
26. Hammond EJ, Uthman BM, Reid SA, Wilder BJ. Electrophysiologic studies of cervical vagus nerve stimulation in humans: II. Evoked potentials. Epilepsia 33, 1021-1028 (1992).
27. Ben-Menachem E, Hamberger A, Hedner T, Hammond EJ, Uthman BM, Slater J. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res. 20, 221-227 (1995).
28. Krahl SE, Clark KB, Smith DC, Browning RA. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39, 709-714 (1998).
29. Mu Q, Bohning DE, Nahas Z et al. Acute vagus nerve stimulation using different pulse width produces varying brain effects. Biol. Psychiatry 55, 816-825 (2004). • Neuroimaging findings in antidepressant VNS is described.
30. Chae JH, Nahas Z, Lomarev M et al. A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J. Psychiatric. Res. 37, 443-455 (2003).
31. Henry TR. Therapeutic mechanism of vagus nerve stimulation. Neurology 59, 3-14 (2002).
32. Smith B, Shatz R, Elisevich K, Bespalova IN, Burmeister M. Effects of vagus nerve stimulation on progressive myoclonus epilepsy of Unverricht-Lundborg type. Epilepsia 41, 1046-1048 (2000).
33. Brody AL, Saxena S, Mandelkern MA, Fairbanks LA, Ho ML, Baxter LR. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol. Psychiatry 50, 171-178 (2001).
34. Nahas Z, Teneback C, Chae JH et al. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology 32, 1649-1660 (2007).
35. Henry TR, Bakay RAE, Votaw JR et al. Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia 39, 983-990 (1998).
36. Mayberg HS, Brannan SK, Mahurin RK et al. Cingulate function in depression: a potential predictor of treatment response. Neuro. Report 8, 1057-1061 (1997).
37. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE. Effect of sleep deprivation on brain metabolism of depressed patients. Am. J. Psychiatry 149, 538-543 (1992).
38. Ebert D, Feistel H, Kaschka W, Barocka A, Pimer A. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation - preliminary results. Biol. Psychiatry 35, 880-885 (1994).
39. Münchau A, Bloem BR, Irlbacher K, Trimble MR, Rothwell JC. Functional connectivity of human premotor and motor cortex explored with repetitive transcranial magnetic stimulation. J. Neurosci. 22, 554-561 (2002).
40. Herwig U, Bräuer K, Connemann B, Spitzer M, Schönfeldt-Lecuona C. Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology (Berl.) 164, 228-232 (2002).
41. Manganotti P, Bortolomasi M, Zanette G, Pawelzik T, Giacopuzzi M, Fiaschi A. Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation. J. Neurol. Sci. 184, 27-32 (2001).
42. Bajbouj M, Lang UE, Niehaus L, Hellen FE, Heuser I, Neu P. Effects of right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients. J. Psychiatr. Res. 40, 322-327 (2005).
43. Bajbouj M, Brakemeier EL, Schubert F et al. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex and cortical excitability in patients with major depressive disorder. Exp. Neurol. 196, 332-338 (2005).
44. Bajbouj M, Gallinat J, Lang UE et al. Motor cortex excitability after vagus nerve stimulation in major depression. J. Clin. Psychopharmacol. 27, 156-159 (2007). • Describes the anticonvulsant effects of VNS in depressive patients.
45. Di Lazzaro V, Oliviero A, Pilato F et al. Effects of vagus nerve stimulation on cortical excitability in epileptic patients. Neurology 62, 2310-2312 (2004).
46. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp. Brain Res. 109, 127-135 (1996).
47. Hanajima R, Ugawa Y, Terao Y et al. Paired- pulse magnetic stimulation of the human motor cortex: differences among I waves. J. Physiol. 509(Pt 2), 607-618 (1998).
48. Sanger TD, Garg RR, Chen R. Interactions between two different inhibitory systems in the human motor cortex. J. Physiol. 530, 307-317 (2001).
49. Sanacora G, Mason GF, Rothman DL et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am. J. Psychiatry 160, 577-579 (2003).
50. Sanacora G, Mason GF, Rothman DL, Krystal JH. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am. J. Psychiatry 159, 663-665 (2002).
51. Bajbouj M, Lisanby SH, Lang UE, Danker-Hopfe H, Heuser I, Neu P. Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol. Psychiatry 59, 395-400 (2006).
52. Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J. ECT 15, 5-26 (1999).
53. Bajbouj M, Gallinat J, Lang UE et al. Motor cortex excitability after vagus nerve stimulation in major depression. J. Clin. Psychopharmacol. 27, 156-159 (2007).
54. Walker BR, Easton A, Gale K. Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia 40, 1051-1057 (1999).
55. Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci. Biobehav. Rev. 31(6), 858-873 (2007). • Describes the phenomenon of kindling.